Adaptive Biotechnologies Corporation (ADPT)

Adaptive Biotechnologies Stock Forecast

Stock Price Forecast

The 5 analysts with 12-month price forecasts for Adaptive Biotechnologies stock have an average target of 9.40, with a low estimate of 6.00 and a high estimate of 12. The average target predicts an increase of 22.56% from the current stock price of 7.67.

Analyst Consensus: Strong Buy

Target	Low	Average	Median	High
Price	$6.00	$9.40	$9.00	$12
Change	-21.77%	+22.56%	+17.34%	+56.45%

Analyst Ratings

The average analyst rating for Adaptive Biotechnologies stock from 5 stock analysts is "Strong Buy". This means that analysts believe this stock is likely to perform very well in the near future and significantly outperform the market.

Recommendation Trends

Rating	Oct '24	Nov '24	Dec '24	Jan '25	Feb '25	Mar '25
Strong Buy	1	1	1	1	1	2
Buy	2	2	2	2	3	3
Hold	2	1	1	1	1	0
Sell	0	0	0	0	0	0
Strong Sell	0	0	0	0	0	0
Total	5	4	4	4	5	5

Latest Forecasts

Analyst	Firm	Rating	Rating	Action	Price Target	Upside	Date
Salveen Richter Goldman Sachs	Goldman Sachs	Hold → Strong Buy Upgrades $8 → $9	Hold → Strong Buy	Upgrades	$8 → $9	+17.34%	Mar 21, 2025
David Westenberg Piper Sandler	Piper Sandler	Buy Reiterates $7 → $11	Buy	Reiterates	$7 → $11	+43.42%	Feb 20, 2025
Sung Ji Nam Scotiabank	Scotiabank	Buy Maintains $10 → $12	Buy	Maintains	$10 → $12	+56.45%	Feb 13, 2025
Salveen Richter Goldman Sachs	Goldman Sachs	Hold Maintains $5.5 → $7.5	Hold	Maintains	$5.5 → $7.5	-2.22%	Jan 28, 2025
Mark Massaro BTIG	BTIG	Strong Buy Maintains $8 → $9	Strong Buy	Maintains	$8 → $9	+17.34%	Dec 18, 2024

More Analyst Ratings

Financial Forecast

Revenue This Year

216.91M

Increased by 21.21%

from 178.96M

Revenue Next Year

264.58M

Increased by 21.98%

from 216.91M

EPS This Year

-0.94

from -1.08

EPS Next Year

-0.71

from -0.94

Fiscal Year	FY 2020	FY 2021	FY 2022	FY 2023	FY 2024	FY 2025	FY 2026	FY 2027
Period Ending	Dec 31, 2020	Dec 31, 2021	Dec 31, 2022	Dec 31, 2023	Dec 31, 2024	Dec 31, 2025	Dec 31, 2026	Dec 31, 2027
Revenue	98.38M	154.34M	185.31M	170.28M	178.96M	216.91M	264.58M	328.02M
Revenue Growth	15.65%	56.88%	20.06%	-8.11%	5.10%	21.21%	21.98%	23.98%
EPS	-1.11	-1.48	-1.40	-1.56	-1.08	-0.94	-0.71	-0.40
EPS Growth	-	-	-	-	-	-	-	-
Forward PE	-	-	-	-	-	-	-	-
No. Analysts	-	-	-	-	-	10	10	7

Historical EPS numbers are GAAP, while forecasted numbers may be non-GAAP.

Revenue Forecast

Revenue	2025	2026	2027	2028
High	228.9M	286.4M	359.7M
Avg	216.9M	264.6M	328.0M
Low	202.4M	237.7M	307.6M

Revenue Growth

Revenue Growth	2025	2026	2027	2028
High	27.9%	32.0%	36.0%
Avg	21.2%	22.0%	24.0%
Low	13.1%	9.6%	16.3%

EPS Forecast

EPS	2025	2026	2027
High	-0.87	-0.60	-0.29
Avg	-0.94	-0.71	-0.40
Low	-1.02	-0.93	-0.46

EPS Growth

EPS Growth	2025	2026	2027
High	-	-	-
Avg	-	-	-
Low	-	-	-

Sources: Price targets and analyst ratings provided by Benzinga. Revenue and EPS forecast data provided by Finnhub. The data is sourced from Wall Street analysts. Data disclaimer.